Clinical efficacy and mechanism of Pralatrexate combined with Palbociclib Isethionate in treatment of bladder cancer patients

The clinical efficacy and mechanism of Pralatrexate (PTX) combined with Palbociclib Isethionate (PAL) in the treatment of bladder cancer patients was investigated. A retrospective analysis of medical records of 82 bladder cancer patients admitted to Shengjing Hospital of China Medical University fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaobin, Wang, Huihan, Song, Yongsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313094/
https://www.ncbi.nlm.nih.gov/pubmed/30655756
http://dx.doi.org/10.3892/ol.2018.9617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313094/
https://www.ncbi.nlm.nih.gov/pubmed/30655756
http://dx.doi.org/10.3892/ol.2018.9617

Ejemplares similares